Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials.
<h4>Background</h4>Mild cognitive impairment (MCI) refers to a transitional zone between normal ageing and dementia. Despite the uncertainty regarding the definition of MCI as a clinical entity, clinical trials have been conducted in the attempt to study the role of cholinesterase inhibi...
Enregistré dans:
Auteurs principaux: | Roberto Raschetti, Emiliano Albanese, Nicola Vanacore, Marina Maggini |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2007
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5877d46e95784f1c9c1d6c47a7760ce7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Screening for mild cognitive impairment in people with obesity: a systematic review
par: Nimantha Karunathilaka, et autres
Publié: (2021) -
Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer's disease.
par: Xiong Jiang, et autres
Publié: (2021) -
Cognitive Intervention Using Information and Communication Technology for Older Adults with Mild Cognitive Impairment: A Systematic Review and Meta-Analysis
par: Ae-Ri Jung, et autres
Publié: (2021) -
Donepezil for mild cognitive impairment in Parkinson’s disease
par: Kyoungwon Baik, et autres
Publié: (2021) -
Caregivers in China: knowledge of mild cognitive impairment.
par: Baozhen Dai, et autres
Publié: (2013)